Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions
The invention provides a method for the palliation of bone pain due to cancer by the administration of a unique dosage of a tin-117m (Sn-117m) stannic chelate complex in a pharmaceutically acceptable composition. In addition, the invention provides a method for simultaneous palliation of bone pain and radiotherapy in cancer patients using compositions containing Sn-117m chelates. The invention also provides a method for palliating bone pain in cancer patients using Sn-117m-containing compositions and monitoring patient status by imaging the distribution of the Sn-117m in the patients. Also provided are pharmaceutically acceptable compositions containing Sn-117m chelate complexes for the palliation of bone pain in cancer patients. 5 figs.
- Research Organization:
- Associated Universities Inc
- Sponsoring Organization:
- USDOE, Washington, DC (United States)
- DOE Contract Number:
- AC02-76CH00016
- Assignee:
- Brookhaven Science Associates LLC, Upton, NY (United States)
- Patent Number(s):
- US 5,853,695/A/
- Application Number:
- PAN: 8-743,287
- OSTI ID:
- 321189
- Country of Publication:
- United States
- Language:
- English
Similar Records
Therapeutic tin-117m compositions
Formulation for tin-{sup 117m}/diethylenetriaminepentaacetic acids